STROKE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=586753, encodeId=8125586e5339, content=我投了一篇，第二天就是under review了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3012, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962640, encodeId=98819626406c, content=投稿Under Review 3周后，拒稿！收到了不错的修改意见！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2689, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211023/2fef6be5850740ce9fb07e791eb5d403/27538cddb8e749758f22e1a6de1e8b8c.jpg, createdBy=a7a25413633, createdName=ms6000001112278624, createdTime=Tue May 04 16:37:46 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074999, encodeId=79df10e499977, content=偏重的研究方向：Stroke;心脑血管 经验分享：投了以后就“under review"了，现在已经22天了，还是一点反应都没有，有没有大佬有经验的，这种送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230119/92867d2d503a46b9b4aab36962691070/013afec2a8d0401492510d259bb02854.jpg, createdBy=513f5421905, createdName=蔡远坤, createdTime=Mon Nov 29 10:13:11 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]

2020-03-16 临床设计

我投了一篇，第二天就是under review了

3012 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=586753, encodeId=8125586e5339, content=我投了一篇，第二天就是under review了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3012, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962640, encodeId=98819626406c, content=投稿Under Review 3周后，拒稿！收到了不错的修改意见！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2689, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211023/2fef6be5850740ce9fb07e791eb5d403/27538cddb8e749758f22e1a6de1e8b8c.jpg, createdBy=a7a25413633, createdName=ms6000001112278624, createdTime=Tue May 04 16:37:46 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074999, encodeId=79df10e499977, content=偏重的研究方向：Stroke;心脑血管 经验分享：投了以后就“under review"了，现在已经22天了，还是一点反应都没有，有没有大佬有经验的，这种送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230119/92867d2d503a46b9b4aab36962691070/013afec2a8d0401492510d259bb02854.jpg, createdBy=513f5421905, createdName=蔡远坤, createdTime=Mon Nov 29 10:13:11 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]

2021-05-04 ms6000001112278624

投稿Under Review 3周后，拒稿！收到了不错的修改意见！

2689 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=586753, encodeId=8125586e5339, content=我投了一篇，第二天就是under review了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3012, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962640, encodeId=98819626406c, content=投稿Under Review 3周后，拒稿！收到了不错的修改意见！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2689, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211023/2fef6be5850740ce9fb07e791eb5d403/27538cddb8e749758f22e1a6de1e8b8c.jpg, createdBy=a7a25413633, createdName=ms6000001112278624, createdTime=Tue May 04 16:37:46 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074999, encodeId=79df10e499977, content=偏重的研究方向：Stroke;心脑血管 经验分享：投了以后就“under review"了，现在已经22天了，还是一点反应都没有，有没有大佬有经验的，这种送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230119/92867d2d503a46b9b4aab36962691070/013afec2a8d0401492510d259bb02854.jpg, createdBy=513f5421905, createdName=蔡远坤, createdTime=Mon Nov 29 10:13:11 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]

2021-11-29 蔡远坤

偏重的研究方向：Stroke;心脑血管
经验分享：投了以后就“under review"了，现在已经22天了，还是一点反应都没有，有没有大佬有经验的，这种送审了吗？

3107 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=586753, encodeId=8125586e5339, content=我投了一篇，第二天就是under review了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3012, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962640, encodeId=98819626406c, content=投稿Under Review 3周后，拒稿！收到了不错的修改意见！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2689, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211023/2fef6be5850740ce9fb07e791eb5d403/27538cddb8e749758f22e1a6de1e8b8c.jpg, createdBy=a7a25413633, createdName=ms6000001112278624, createdTime=Tue May 04 16:37:46 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074999, encodeId=79df10e499977, content=偏重的研究方向：Stroke;心脑血管 经验分享：投了以后就“under review"了，现在已经22天了，还是一点反应都没有，有没有大佬有经验的，这种送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230119/92867d2d503a46b9b4aab36962691070/013afec2a8d0401492510d259bb02854.jpg, createdBy=513f5421905, createdName=蔡远坤, createdTime=Mon Nov 29 10:13:11 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]

2020-05-01 741040263_45099105

中了呢临床设计 2020-03-16 00:00:00 发表:
我投了一篇，第二天就是under review了

临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了

3167 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=586753, encodeId=8125586e5339, content=我投了一篇，第二天就是under review了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3012, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962640, encodeId=98819626406c, content=投稿Under Review 3周后，拒稿！收到了不错的修改意见！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2689, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211023/2fef6be5850740ce9fb07e791eb5d403/27538cddb8e749758f22e1a6de1e8b8c.jpg, createdBy=a7a25413633, createdName=ms6000001112278624, createdTime=Tue May 04 16:37:46 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074999, encodeId=79df10e499977, content=偏重的研究方向：Stroke;心脑血管 经验分享：投了以后就“under review"了，现在已经22天了，还是一点反应都没有，有没有大佬有经验的，这种送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230119/92867d2d503a46b9b4aab36962691070/013afec2a8d0401492510d259bb02854.jpg, createdBy=513f5421905, createdName=蔡远坤, createdTime=Mon Nov 29 10:13:11 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]

2021-11-29 14612008m08(暂无昵称)

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：脑卒中
经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿

2152 0

[GetPortalCommentsPageByObjectIdResponse(id=586753, encodeId=8125586e5339, content=我投了一篇，第二天就是under review了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3012, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962640, encodeId=98819626406c, content=投稿Under Review 3周后，拒稿！收到了不错的修改意见！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2689, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211023/2fef6be5850740ce9fb07e791eb5d403/27538cddb8e749758f22e1a6de1e8b8c.jpg, createdBy=a7a25413633, createdName=ms6000001112278624, createdTime=Tue May 04 16:37:46 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074999, encodeId=79df10e499977, content=偏重的研究方向：Stroke;心脑血管 经验分享：投了以后就“under review"了，现在已经22天了，还是一点反应都没有，有没有大佬有经验的，这种送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230119/92867d2d503a46b9b4aab36962691070/013afec2a8d0401492510d259bb02854.jpg, createdBy=513f5421905, createdName=蔡远坤, createdTime=Mon Nov 29 10:13:11 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]

2021-10-23 ms3000001635648837

偏重的研究方向：Stroke;脑缺血
经验分享：2天就被拒了，不耽误事

773 0

[GetPortalCommentsPageByObjectIdResponse(id=586753, encodeId=8125586e5339, content=我投了一篇，第二天就是under review了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3012, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962640, encodeId=98819626406c, content=投稿Under Review 3周后，拒稿！收到了不错的修改意见！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2689, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211023/2fef6be5850740ce9fb07e791eb5d403/27538cddb8e749758f22e1a6de1e8b8c.jpg, createdBy=a7a25413633, createdName=ms6000001112278624, createdTime=Tue May 04 16:37:46 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074999, encodeId=79df10e499977, content=偏重的研究方向：Stroke;心脑血管 经验分享：投了以后就“under review"了，现在已经22天了，还是一点反应都没有，有没有大佬有经验的，这种送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230119/92867d2d503a46b9b4aab36962691070/013afec2a8d0401492510d259bb02854.jpg, createdBy=513f5421905, createdName=蔡远坤, createdTime=Mon Nov 29 10:13:11 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]

2021-06-08 医学生的成长

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向： Stroke
经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些

1065 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=586753, encodeId=8125586e5339, content=我投了一篇，第二天就是under review了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3012, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962640, encodeId=98819626406c, content=投稿Under Review 3周后，拒稿！收到了不错的修改意见！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2689, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211023/2fef6be5850740ce9fb07e791eb5d403/27538cddb8e749758f22e1a6de1e8b8c.jpg, createdBy=a7a25413633, createdName=ms6000001112278624, createdTime=Tue May 04 16:37:46 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074999, encodeId=79df10e499977, content=偏重的研究方向：Stroke;心脑血管 经验分享：投了以后就“under review"了，现在已经22天了，还是一点反应都没有，有没有大佬有经验的，这种送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230119/92867d2d503a46b9b4aab36962691070/013afec2a8d0401492510d259bb02854.jpg, createdBy=513f5421905, createdName=蔡远坤, createdTime=Mon Nov 29 10:13:11 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]

2018-10-25 weilinjie

外审了，被录用的机率多大

454 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=586753, encodeId=8125586e5339, content=我投了一篇，第二天就是under review了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3012, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962640, encodeId=98819626406c, content=投稿Under Review 3周后，拒稿！收到了不错的修改意见！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2689, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211023/2fef6be5850740ce9fb07e791eb5d403/27538cddb8e749758f22e1a6de1e8b8c.jpg, createdBy=a7a25413633, createdName=ms6000001112278624, createdTime=Tue May 04 16:37:46 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074999, encodeId=79df10e499977, content=偏重的研究方向：Stroke;心脑血管 经验分享：投了以后就“under review"了，现在已经22天了，还是一点反应都没有，有没有大佬有经验的，这种送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230119/92867d2d503a46b9b4aab36962691070/013afec2a8d0401492510d259bb02854.jpg, createdBy=513f5421905, createdName=蔡远坤, createdTime=Mon Nov 29 10:13:11 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]

2019-11-13 ms5624929764890046

很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。

264 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=586753, encodeId=8125586e5339, content=我投了一篇，第二天就是under review了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3012, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Mon Mar 16 00:00:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962640, encodeId=98819626406c, content=投稿Under Review 3周后，拒稿！收到了不错的修改意见！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2689, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211023/2fef6be5850740ce9fb07e791eb5d403/27538cddb8e749758f22e1a6de1e8b8c.jpg, createdBy=a7a25413633, createdName=ms6000001112278624, createdTime=Tue May 04 16:37:46 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074999, encodeId=79df10e499977, content=偏重的研究方向：Stroke;心脑血管 经验分享：投了以后就“under review"了，现在已经22天了，还是一点反应都没有，有没有大佬有经验的，这种送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230119/92867d2d503a46b9b4aab36962691070/013afec2a8d0401492510d259bb02854.jpg, createdBy=513f5421905, createdName=蔡远坤, createdTime=Mon Nov 29 10:13:11 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590083, encodeId=e66f59008321, content=中了呢临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, beContent=临床设计 2020-03-16 00:00:00 发表: 我投了一篇，第二天就是under review了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c5306171, createdName=741040263_45099105, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074990, encodeId=d17410e4990e9, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：脑卒中 经验分享：不符合期刊要求的感觉最迟两周就会拒稿了，一般一周内就会拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236e5110114, createdName=14612008m08(暂无昵称), createdTime=Mon Nov 29 09:56:18 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063215, encodeId=e8141063215be, content=偏重的研究方向：Stroke;脑缺血 经验分享：2天就被拒了，不耽误事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=773, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=ms3000001635648837, createdTime=Sat Oct 23 18:53:46 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971776, encodeId=847d9e17761c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向： Stroke 经验分享：刚接受了一篇，初审仅13天，第一次修回后审了2个月，增加了一个审稿人意见，第二次修回后1个月接收，整体效率还是比较高的，之前效率更高，可能由于疫情影响，所以慢了一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/10/f6867fab12bd4b1afd312764f9c5dcbc.jpg, createdBy=faae1673358, createdName=医学生的成长, createdTime=Tue Jun 08 10:50:00 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562361, encodeId=e5e556236173, content=外审了，被录用的机率多大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c14110149, createdName=weilinjie, createdTime=Thu Oct 25 00:00:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854940, encodeId=e337854940a6, content=很扎实的杂志，审稿人也很用心的指出问题帮助完善文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Wed Nov 13 10:47:49 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]

2020-02-28 1480aa6cm65(暂无昵称)

审稿速度:1.0 | 投稿命中率:25.0
经验分享：2020.2.12投，2.18拒

240 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务